# US 2013/0157875 A1 · Methods for assessing genomic instabilities

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2013/0157875 A1
- Document ID: US20130157875A1
- Status: Published application
- Kind: A1
- Application number: 13/741,183
- Filed: 2013-01-14
- Published: 2013-06-20
- Earliest claimed: 2011-07-20
- Inventors: Anthony P. Shuber
- Web page: https://patentgrep.com/patent/US20130157875A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

The invention generally relates to methods for assessing a fetal abnormality.

## Claims

### Claim 1

A method of assessing a fetal abnormality, the method comprising:
analyzing a nucleic acid from a sample comprising fetal nucleic acid;
identifying one or more genomically unstable loci in the nucleic acid;
assigning a weighted value to each genomically unstable locus; and
assessing a fetal abnormality based on the weighted values.

### Claim 2 (depends on 1)

The method according to claim 1, wherein the weighed value is based on severity of the genomically unstable locus.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the weighted value is based on a type of genomic instability.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the type of genomic instability is selected from the group consisting of additions, deletions, substitutions, translocations, alterations, amplifications, and single nucleotide polymorphisms.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the weighted value is based on a location of the genomically unstable locus.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the location is selected from the group consisting of: location on a chromosome, proximity to telomeres, and proximity to known or suspected locations of genomic instabilities found in certain fetal abnormalities.

### Claim 7 (depends on 1)

The method according to claim 1, wherein the weighted value is based on a number of nucleotides within each genomically unstable locus.

### Claim 8 (depends on 1)

The method according to claim 1, wherein analyzing comprises sequencing the nucleic acid.

### Claim 9 (depends on 8)

The method according to claim 8, wherein sequencing is sequencing-by-synthesis.

### Claim 10 (depends on 8)

The method according to claim 8, wherein identifying comprises comparing the sequenced nucleic acid to a reference nucleic acid to thereby identify the genomically unstable loci.

### Claim 11 (depends on 1)

The method according to claim 1, wherein prior to the assigning step, the method further comprises categorizing the genomically unstable loci.

### Claim 12 (depends on 11)

The method according to claim 11, further comprising deriving a weighted sum for each category.

### Claim 13 (depends on 11)

The method according to claim 11, wherein categorizing is based on a type of genomic instability.

### Claim 14 (depends on 11)

The method according to claim 11, wherein categorizing is based on a location of the genomically unstable locus.

### Claim 15 (depends on 1)

The method according to claim 1, wherein the sample is a maternal sample.

### Claim 16 (depends on 15)

The method according to claim 15, wherein the maternal sample is blood or amniotic fluid.

### Claim 17 (depends on 1)

The method according to claim 1, wherein the sample is a fetal sample.
